Appearing at the German medical exhibition to showcase genetic innovations Exhibition Scene

Recently, the 55th Medica exhibition was grandly opened in Dülsev, Germany. As the world’s largest hospital and medical equipment exhibition, it attracted many medical equipment and solution providers from all over the world, and it is a leading global medical event, which lasted for four days and brought together medical experts, scholars and entrepreneurs and other people from all over the world.

As a leader in the field of genetic testing in China, Bigfish has been committed to promoting the innovation and development of genetic testing technology. This time, Bigfish sent representatives with its latest research results and products to show the company’s leading strength in the field of genetic testing to the world.

Product Show

The product lineup of this exhibition is luxurious, including 96 nucleic acid extraction instrument, 96 fluorescence quantitative analyzer, portable gene amplifier and rapid gene detector and its supporting reagents. In this exhibition, Bigfish Heavy demonstrated for the first time a molecular POCT device that integrates extraction and amplification – Rapid Gene Detector. This instrument adopts advanced detection technology, which can realize the whole process of sample extraction and amplification in a short time, and can directly draw negative and positive conclusions, truly realizing “sample in, result out”. In addition to qualitative testing, quantitative testing and melting curve analysis can also be done, “small as a sparrow”, but the performance is fully comparable to large workstation equipment. The launch of this instrument not only improves the efficiency of genetic testing, but also greatly reduces the difficulty of operation and manual errors.

In addition, Bigfish also displayed its real-time fluorescence quantitative PCR analyzer, portable gene amplifier, 96 nucleic acid extractor and other supporting reagents and so on. These instruments are indispensable experimental equipment in the field of biomedicine, each of them has different functions and characteristics, and can be used in conjunction with each other to provide more reliable and powerful assistance for biomedical research.

Collaborative Exchanges

During the exhibition, Bigfish had in-depth communication and discussion with a number of industry personnel. Both sides exchanged views on medical technology and product issues of common concern and reached preliminary intentions on future cooperation.

During the communication with the partners, Bigfish learned the current development trend and market demand of the medical industry, which provided new ideas and directions for the company’s future development. At the same time, Bigfish also introduced to the partners the company’s advantages in R&D, production and sales, showing the company’s core competitiveness.

The Future is Bright

The exhibition was of great significance for Bigfish. It not only enhances the company’s international influence, but also strengthens the ties with international partners and promotes the company’s globalization strategy. At the same time, it also provides a learning and communication platform for Bigfish to better understand the needs and trends of the global healthcare market.

As a leading company in the field of domestic genetic testing, Bigfish has always insisted on innovation-driven, and continuously improved its R&D strength and technology level. By participating in this exhibition, Bigfish will further consolidate its leading position in the industry and contribute to the development of the global healthcare industry by bringing more surprises and innovations.